ISO 9614-1:2023
Sound Power — Intensity Method (Discrete Points)
This test uses a sound intensity probe to measure acoustic intensity at discrete points on a measurement surface, allowing determination of sound power levels without requiring a fully anechoic environment. The intensity-based approach is effective for characterizing noise sources in semi-reverberant or field conditions where traditional pressure-based methods are unreliable. It provides directional acoustic information and is valuable for source localization and acoustic modification assessment. Accreditation ensures proper probe calibration, measurement procedures, and data processing are maintained to standards.
What it measures
- Sound intensity magnitude and direction (vector)
- Sound power level by surface integration
- A-weighted and frequency-weighted acoustic power
- Sound radiation patterns from complex sources
🇩🇪
DIN EN ISO 9614-2
🇬🇧
BS EN ISO 9614-2
🇫🇷
NF EN ISO 9614-2
🇮🇹
UNI EN ISO 9614-2
🇪🇸
UNE EN ISO 9614-2
🇳🇱
NEN EN ISO 9614-2
🇩🇪
DIN EN ISO 3744
🇬🇧
BS EN ISO 3744
🇫🇷
NF EN ISO 3744
🇮🇹
UNI EN ISO 3744
🇪🇸
UNE EN ISO 3744
🇳🇱
NEN EN ISO 3744
1,670
Accredited labs
18
Countries
Showing 1,551–1,575 of 1,670 labs
Familiäre Adenomatöse Polyposis
Syndrome (APC, MUTYH)
STK11, SMAD4 ), TruRisk® -Panel [SNV, CN
Familiäre Polyposis-Syndrome [FAP]
(APC, MUTYH)
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
alpha-Aminobuttersäure
Mianserin
Arginin
Asparagin
Asparaginsäure
+ 3 more
Candida spp.-Antikörper
Cardiolipin-Antikörper
Meningitiserreger-Ag (E. coli
Staphylococcus aureus
Treponema pallidum-Antikörper
+ 3 more
Granulozytäre Antikörper
(Screening und Differenzierung)
HLA spezifische Antikörper
B-Streptokokken (Screening)
Ektoparasiten (Differenzierung)
+ 3 more
Anti-Thyreoglobulin-Antikörper
[Anti-TG]
Anti-Thyreoperoxidase Antikörper
[Anti-TPO]
Anti-TSH-Rezeptor Antikörper
+ 3 more
angeborener Chromosomensatz
Silver-Russell-Syndrom:
H19, KCNQ1OT1
MEST
Deletion; Angelman-Syndrom
+ 3 more
5-Hydroxyindolessigsäure
Amitriptylin/Nortriptylin
Cyclosporin A
Gesamt-Itraconazol
Metanephrine, Normetanephrine
+ 3 more
IEC 60061-1
IEC 60061-2
IEC 60238
IEC 61184
IEC 60400
+ 3 more
(HSG 248) – 2021
ASB/10 based on HSG 248
(PCM) based on HSG 248
ASB/6 based on HSG 248
BS EN ISO 14644-1:2015
+ 3 more
UNE-EN 60942
UNE-EN 61672-3
UNE 82503
UNE-EN 60804
UNE 20942
+ 3 more
Myopathie, Nemaline (TyP1, 3-10:
ASTM E 23-18
ASTM D 1322
Toxizität UGT1A1-Gen rs3064744, rs414832
DIN EN 1789
+ 3 more
5 a 18 mm/s (Valor pico) (frecuencias en
5 a 12 mm/s (RMS) (frecuencias entre 8 H
VWR International
Active
TEMPERATURE
parameters and ranges)
indicators or recorders
WEIGHING INSTRUMENTS
DIN EN 61466-1
DIN EN 61466-2
DIN 14678
DIN EN 54-2/A1
DIN EN 543
+ 3 more
Vectoflow
Active
am Standort Vectoflow Windtunnel A, Frie
Strömungsgeschwindigkeit
von Gasen 15 m/s bis
> 38 m/s
Blutbild, kleines (Erythrozyten, Leukozy
Erythrozyten
Leukozyten
Retikulozyten
Thrombozyten
+ 3 more
No matching labs found.